Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology

被引：23

作者：

Kim, EE ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging,Unit 59, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2004年 / 14卷 / 01期

关键词：

gynecologic cancer; PET; PET/CT;

D O I：

10.1111/j.1048-891x.2004.14224.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The advent of positron emission tomography (PET) and PET/computed tomography (CT) now enables us to detect metabolically active gynecologic cancers with greater accuracy than was possible with anatomic imagings. Fluorine-18 fluorodeoxyglucose PET has been useful in differentiation of malignant from benign lymph nodes, and residual or recurrent cancers from post-treatment changes. PET/CT produces additional information for the diagnosis and tissue biopsy as well as radiotherapy planning. This paper reviews the principle and clinical utility of PET and PET/CT in the diagnosis, staging, recurrence, therapeutic response as well as prognosis of gynecologic cancers.

引用

页码：12 / 22

页数：11

共 51 条

[1] Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology Part II.: The clinical value in detecting and staging primary tumours [J].